If you rely on Meftal Spas to alleviate pain, menstrual cramps, or manage rheumatoid arthritis, this news is of paramount importance. The Indian Pharmacopoeia Commission (IPC) has issued a critical drug safety alert, sounding the alarm on Meftal’s active ingredient, mefenamic acid. The alert underscores potential adverse reactions that could lead to a severe condition known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.